RDIF: the customers of the campaign against “Sputnik V” were representatives of “big pharma”

The customers of the information campaign against the Russian coronavirus vaccine “Sputnik V” are representatives of “big pharma”, said Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF). “Big Pharma” includes about 30 of the world’s leading drug manufacturers, including Pfizer, Moderna, AstraZeneca, Johnson & Johnson corporations, which also produce vaccines against COVID-19.

“We believe that the initiators of this process are a number of big pharma companies and anti-Russian political circles. From the very beginning, there was a purposeful campaign to undermine confidence in the great achievement of our scientists, in the effectiveness of the vaccine, ”said Mr. Dmitriev to RBC. He said that the information campaign against Sputnik V began even before its registration in September 2020, when statements about the theft of the drug production technology began to be heard.

According to him, the information campaign against the vaccine is also aimed at reducing the rate of vaccination in the country. “We see attacks on Sputnik V primarily in the Anglo-Saxon press – this is a kind of octopus combining the interests of a number of big pharma companies and a number of political players who are opposed to Russia,” said the head of the RDIF.

Earlier, Mr. Dmitriev said about the rush demand around “Sputnik V” in the world. The Russian drug has been approved in 66 countries with a total population of over 3.2 billion people. The effectiveness of the drug is 97.6%. On March 4, the relevant European regulator (EMA) announced the start of the procedure for the sequential examination of the vaccine.

For more information about vaccination in the world, see the article “Carpet Vaccinations” by Kommersant.